A Phase 2 study published in the New England Journal of Medicine in 2023 (Jastreboff et al.) reported substantial weight loss in participants with obesity
Medical oversight from licensed providers Pharmaceutical-grade peptide sourcing Personalized protocols Lab monitoring when appropriate Education and follow-up support A functional-health approach focused on cellular wellness Do you offer peptide programs or packages
Always consult licensed healthcare providers for personalized medical advice
Gene Expression Analysis Gene expression analysis revealed overlapping patterns between ketamine and BPC-157 effects on Nos1 (neuronal NOS), Nos2 (inducible NOS), Plcg1, Prkcg, and Ptgs2 (COX-2)
Do not wait for routine labs Severe abdominal pain, persistent vomiting, signs of dehydration, fainting, allergic symptoms, or severe low-glucose symptoms need medical review
If you see any of these, continue gentle swirling